Molecular Instruments & Empire Genomics Launch NISH Powered by HCR™ Pro: The Largest Ready-to-Use, Fully Automated ISH Library, Exclusively Available Worldwide on NeoPATH Pro
On May 5, 2026, Empire Genomics, a subsidiary of Biocare Medical, and Molecular Instruments® (MI) introduced NISH (Neo in situ hybridization) in Los Angeles and Buffalo, N.Y. NISH is the most extensive fully automated ISH library available and is based on the HCR™ technology, pioneered by MI's founder.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments